Shares in Medica (LON:MGP) are currently trading at 168p but a key question for investors is how the economic uncertainty caused by Covid-19 will affect the price. The answer comes down to judging whether it is well placed to withstand...
|Type||Buy / Hold / Sell|
|Year End 31st Dec||Unit||2016||2017||2018||2019||2020||2021E||2022E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Latest News & Insights for MGP
Quality and momentum are highly prized among investors looking for reliable investment ideas. That's because good quality stocks tend to be resilient, cash-generating businesses that can compound investment returns over time. And those...
Covid-19 has shaken world markets and a question on the minds of many investors right now is how economic uncertainty will continue to affect small-cap shares like Medica (LON:MGP). Shares in the company are currently trading at 164p....
Company analysts usually understand the stocks they cover better than just about anyone else. For that reason, it can be useful to know whether they think investors should 'buy', 'hold' or 'sell' them. These kinds of clues can give you...
Shares in Medica (LON:MGP) are currently trading at 169p but a key question for investors is how the economic uncertainty caused by Covid-19 will affect the price. The answer comes down to judging whether it is well placed to withstand...
Medica Group PLC is a United Kingdom-based company, which is engaged in the provision of teleradiology services. The Company offers an information technology (IT) platform that provides linkage between a hospital's radiology information system (RIS) and consultant radiologists who contract with the Company. The Company operates through Teleradiology reporting segment. The Company offers three services to hospital radiology departments: NightHawk, Routine cross-sectional (Routine CS) and Routine plain film (Routine PF). The Company's NightHawk service is an out of hours service to hospital emergency departments, offering always on support around the clock. NightHawk provides reporting on Computerized Tomography (CT) scans. Its Routine CS and Routine PF are both designed to assist hospitals in managing their daytime capacity and turnaround times. It provides Teleradiology services to NHS hospitals, private hospital groups and diagnostic imaging businesses.
- Sixth Floor, One Priory Square, HASTINGS, TN34 1EA
- Grant Thornton UK LLP
Latest News for MGP
Upcoming Events for MGP
Full Year 2021 Medica Group PLC Earnings Release
As of Today at 22:58 UTC, shares in Medica are trading at 160.00p. This share price information is delayed by 15 minutes.
Shares in Medica last closed at 160.00p and the price had moved by +33.33% over the past 365 days. In terms of relative price strength the Medica share price has outperformed the FTSE All Share Index by +21.47% over the past year.
The overall consensus recommendation for Medica is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Medica dividend yield is 1.62% based on the trailing twelve month period.
Last year, Medica paid a total dividend of £0.03, and it currently has a trailing dividend yield of 1.62%. We do not have any data on when Medica is to next pay dividends.
We do not have data on when Medica is to next pay dividends. The historic dividend yield on Medica shares is currently 1.62%.
To buy shares in Medica you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 160.00p, shares in Medica had a market capitalisation of £195.89m.
Here are the trading details for Medica:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: MGP
Based on an overall assessment of its quality, value and momentum Medica is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Medica is 208.60p. That is 30.38% above the last closing price of 160.00p.
Analysts covering Medica currently have a consensus Earnings Per Share (EPS) forecast of £0.08 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medica. Over the past six months, its share price has underperformed the FTSE All Share Index by -1.6%.
As of the last closing price of 160.00p, shares in Medica were trading -0.59% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medica PE ratio based on its reported earnings over the past 12 months is 17.38. The shares last closed at 160.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Medica's management team is headed by:
- Gordon Davis - NEC
- Stuart Quin - CEO
- Richard Jones - CFO
- Robert Lavis - OTH
- Junaid Bajwa - NID
- Joanne Easton - NID
- Barbara Moorhouse - NID